Are predictive biomarkers the wave of the future of depression treatment?
Recent research has demonstrated — in small pilot studies — that brain PET scans and, in a separate study, blood proteins, may act as important biomarkers for determining whether an antidepressant or cognitive behavioral therapy might be the best treatment for a person’s clinical depression.
Such an indicator would be a potential boon for those seeking treatment for depression. Currently, depression treatment is characterized by a trial-and-error approach, with most professionals recommending most people get both medications and psychotherapy.
These studies point to the possibility that, in the future, we may have a more reliable way of directing people to the treatment that’s going to be the most effective for them.